Systematic Review Thesis

Comparative Effects of Stimulants and Atomoxetine on Emotional & Functional Outcomes in ADHD

An academic MD systematic review exploring how stimulant and non-stimulant pharmacotherapies shape emotional regulation, daily functioning, and treatment trajectories in ADHD across youth and adult populations.

Explore the Thesis Read Introduction
Thesis Abstract

Reframing ADHD treatment beyond symptom scores

This systematic narrative review reframes ADHD treatment response around emotional stability and functional performance, arguing that effective pharmacotherapy must be assessed through clinically meaningful daily-life outcomes as well as core symptom reduction.

Abstract cognitive thoughts representing ADHD mental processing
Background

ADHD is more than a disorder of inattention, impulsivity, and hyperactivity. Emotional dysregulation, including mood instability, emotional overreactivity, and temper dyscontrol, contributes materially to patient burden, while functional capacity shapes how symptoms translate into school performance, social participation, and quality of life.

These broader outcomes remain comparatively understudied in pharmacotherapy research, even though they are central to whether treatment success is actually experienced in daily living.

Methods

This thesis used a systematic narrative review design informed by PRISMA principles. Literature was searched through January 2026 using PubMed, Semantic Scholar, and Google Scholar, with terms covering ADHD, emotional dysregulation, functional outcomes, stimulants, and atomoxetine.

Records were screened using title and abstract review followed by full-text assessment, with eligibility centered on original research examining stimulant and/or atomoxetine effects on emotional dysregulation, functional capacity, quality of life, or academic functioning.

Results & Conclusions

The reviewed evidence indicates that both stimulants and atomoxetine improve emotional dysregulation and functional capacity beyond their effects on core ADHD symptoms. Atomoxetine showed durable gains in emotional outcomes in adults, while stimulants were linked with stronger academic and functional gains in youth populations.

Comparative findings further suggest that emotional profiles may predict treatment trajectories, including treatment persistence and switching. The review therefore supports a broader model of ADHD pharmacotherapy in which emotional stability and real-world functioning are treated as equally valid treatment endpoints.

Key Takeaway

Stimulants and atomoxetine both matter clinically, but their value is best understood through the combined lenses of emotional regulation, functional performance, and individualized response profiles rather than symptom reduction alone.

Thesis Identity

Academic rigor with a modern presentation layer

Five pages cover the introduction, methods, results, and discussion. Core claims appear in each section.

Author
Mohamed Salaheddin Abdulrahman Shembesh
Institution
University of Debrecen
Thesis Year
2026
Reading Path

Navigate the thesis as a research story

  • The introduction expands the rationale for treating emotional dysregulation and functional impairment as valid endpoints.
  • The methods page clarifies the PRISMA-informed search and eligibility logic.
  • The results page translates the evidence into tabbed thematic sections and a summary table.
  • The discussion page closes with clinical meaning, limitations, and future directions for precision prescribing.